US 12351625
Therapeutic antibodies against osteopontin
granted A61KA61K31/397A61K31/4184
Quick answer
US patent 12351625 (Therapeutic antibodies against osteopontin) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/397, A61K31/4184, A61K31/519, A61K47/00